On Friday, Johnson & Johnson (NYSE: JNJ) was 0.99% up from the session before settling in for the closing price of $164.23. A 52-week range for JNJ has been $143.13 – $165.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 1.31%. When this article was written, the company’s average yearly earnings per share was at 0.74%. With a float of $2.40 billion, this company’s outstanding shares have now reached $2.41 billion.
Let’s determine the extent of company efficiency that accounts for 131900 employees. In terms of profitability, gross margin is 71.28%, operating margin of 25.96%, and the pretax margin is 22.53%.
Johnson & Johnson (JNJ) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Johnson & Johnson stocks. The insider ownership of Johnson & Johnson is 0.13%, while institutional ownership is 73.16%. The most recent insider transaction that took place on Aug 30 ’24, was worth 930,113. Before that another transaction happened on Mar 13 ’24, when Company’s EVP, Global Corp Affairs sold 8,891 for $162.16, making the entire transaction worth $1,441,765. This insider now owns 15,043 shares in total.
Johnson & Johnson (JNJ) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted 2.66 earnings per share (EPS) during the time that was better than consensus figure (set at 2.52) by 0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.74% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.53% during the next five years compared to -0.27% drop over the previous five years of trading.
Johnson & Johnson (NYSE: JNJ) Trading Performance Indicators
You can see what Johnson & Johnson (JNJ) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.61. Likewise, its price to free cash flow for the trailing twelve months is 19.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.92, a number that is poised to hit 2.18 in the next quarter and is forecasted to reach 10.69 in one year’s time.
Technical Analysis of Johnson & Johnson (JNJ)
Looking closely at Johnson & Johnson (NYSE: JNJ), its last 5-days average volume was 6.36 million, which is a drop from its year-to-date volume of 7.27 million. As of the previous 9 days, the stock’s Stochastic %D was 83.94%. Additionally, its Average True Range was 2.27.
During the past 100 days, Johnson & Johnson’s (JNJ) raw stochastic average was set at 99.47%, which indicates a significant increase from 98.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 9.19% in the past 14 days, which was lower than the 18.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $155.74, while its 200-day Moving Average is $154.57. However, in the short run, Johnson & Johnson’s stock first resistance to watch stands at $166.62. Second resistance stands at $167.39. The third major resistance level sits at $168.79. If the price goes on to break the first support level at $164.45, it is likely to go to the next support level at $163.05. Should the price break the second support level, the third support level stands at $162.28.
Johnson & Johnson (NYSE: JNJ) Key Stats
There are 2,406,679K outstanding shares of the company, which has a market capitalization of 399.26 billion. As of now, sales total 85,159 M while income totals 35,153 M. Its latest quarter income was 22,447 M while its last quarter net income were 4,686 M.
